Skip to main content

Publisher: Elsevier

Volume 8, Number 11, 1 June 2003

Biotechs as integrated drug R&D
pp. 469-470(2)
Author: Henco, K.

Favourites:
ADD

Turning a tumour into its own worst enemy
pp. 471-472(2)
Author: Goldman, B.

Favourites:
ADD

Genes go incognito into brain
pp. 473-474(2)
Author: Foubister, V.

Favourites:
ADD

Gene therapy success for Alzheimer's?
pp. 474-475(2)
Author: Brown, M.

Favourites:
ADD

News in brief
pp. 476-478(3)
Authors: Brown, M.; Carey, J.; Deakin, L.; Rathbone, C.; Robertson, M.; Wild, C.; Yeomans., H.

Favourites:
ADD

People
pp. 479-479(1)
Author: Clough, J.

Favourites:
ADD

Off with his head - a tragic tale for chemistry
pp. 480-481(2)
Author: Rowe, R.

Favourites:
ADD
Favourites:
ADD

Engineered T lymphocytes - powerful killers
pp. 483-483(1)
Author: Benvenuti, F.

Favourites:
ADD

New directions in cancer drug development
pp. 485-486(2)
Author: Clough, J.

Favourites:
ADD

Decreasing smoking behaviour and risk through CYP2A6 inhibition
pp. 487-493(7)
Authors: Sellers, E.M.; Tyndale, R.F.; Fernandes, L.C.

Favourites:
ADD
Favourites:
ADD

Renaissance of cancer therapeutic antibodies
pp. 503-510(8)
Authors: Glennie, M.J.; van de Winkel, J.G.J.

Favourites:
ADD

Monitor: molecules and profiles
pp. 511-512(2)
Author: Edwards, P.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more